Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Sponsor: Skyline Therapeutics
Summary
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
Official title: A Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
83
Start Date
2024-04-02
Completion Date
2031-03
Last Updated
2024-04-04
Healthy Volunteers
No
Interventions
SKG0106
Non-interventional (observational) study, long-term follow-up safety and efficacy assessments up to 5 years post SKG0106 injection.
Locations (10)
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Retina Consultants of Texas
Katy, Texas, United States
Wagner Macula & Retina Center
Norfolk, Virginia, United States
The Second Hospital Of Anhui Medical University
Hefei, Anhui, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Eye Hospital, WMU (Zhejiang Eye Hospital)
Wenzhou, Zhejiang, China
Beijing Hospital
Beijing, China
Peking Union Medical College Hospital
Beijing, China
EYE & ENT Hospital of Fudan University
Shanghai, China
Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
Shanghai, China